Chlormadinone acetate is effective for hot flush during androgen deprivation therapy

PURPOSE: To investigate the clinical efficacy of low-dose chlormadinone acetate (CMA) in prostate cancer patients who suffer from hot flushes that is a major side effect of androgen deprivation therapy. METHODS: Our study included 32 prostate cancer patients who had severe hot flush after undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Hidekazu, Morikawa, Yasuyuki, Matsui, Hiroshi, Shibata, Yasuhiro, Ito, Kazuto, Suzuki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society (APPS) 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814123/
https://www.ncbi.nlm.nih.gov/pubmed/24223412
http://dx.doi.org/10.12954/PI.12010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814123/
https://www.ncbi.nlm.nih.gov/pubmed/24223412
http://dx.doi.org/10.12954/PI.12010

Ejemplares similares